MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer

NCT01405586 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

299

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Metastatic
Non-small Cell Lung Cancer Stage IIIB

Interventions

DRUG: Gemcitabine
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

National Cancer Institute, Naples